| |  Investigating a common gene in three very different species – axolotls, mice and zebrafish – scientists have discovered the potential for a novel gene therapy aimed at eventually regrowing limbs in humans, according to new research published this week. | |
|
| |  People with type 2 diabetes on a high-fat, low-carbohydrate diet may have a better chance of reversing their diabetes than those on a low-fat diet, according to a small study published in the Journal of the Endocrine Society. | |
|
| |  Investigating fermented oat and soy drinks, this study highlights their potential to enhance anti-inflammatory bioactivity through lipid transformation. | |
|
| |  UPMC and University of Pittsburgh clinician-scientists have weaned and kept multiple liver transplantation patients off of all immunosuppressant drugs for more than three years through a first-in-human clinical trial of a unique "immune priming" therapy. | |
|
| |  Depending on whom you ask, Alfred Engelberg could be a hero or a villain in the story of American pharmaceuticals. | |
|
| |  Dr. Shagaf Bakour, a gynecologist and director of medical education at Aston Medical School, has won an NHS research grant to investigate the use of weight-loss drugs in the treatment of polycystic ovary syndrome (PCOS). | |
|
| |  Obesity trials are evolving toward chronic disease models with improved endpoints, longer study designs, and greater clinical relevance. | |
|
| |  There may be some truth to the saying "the eyes are the window to the soul." Age-related changes are reflected in the retina, the light-sensitive tissue at the back of the eye. | |
|
| |  Explore emerging strategies to improve clinical outcomes and slow disease progression in patients with diabetic kidney disease. | |
|
| |  Prediabetes may leave a lasting molecular "footprint" on adipose (fat) tissue which appears to make maintaining weight loss after bariatric surgery more difficult, according to new research being presented at this year's European Congress on Obesity (ECO) in Istanbul, Turkey (12-15 May). | |
|
| |  Design and optimize cardiometabolic trials by addressing complexity, endpoints, recruitment, and regulatory requirements. | |
|
| |  Explore how early-phase diabetes trials are evolving beyond glucose control to address broader clinical outcomes and patient complexity. | |
|
| |  BioOrbit is revolutionizing drug delivery with microgravity-grown monoclonal antibodies, enabling self-administered therapies through innovative space biotech. | |
|
| |  Explore new approaches to early-phase MASLD trials, addressing metabolic complexity and improving clinical relevance in study design. | |
